Secondary prophylaxis of venous thromboembolism: rational use of oral anticoagulants.
Piovella
F
F
Istituto di Clinica Medica 2 IRCCS Policlinico S. Matteo, University of Pavia, Italy.
Siragusa
S
S
Barone
M
M
Beltrametti
C
C
Carbone
S
S
Vicentini
L
L
Ascari
E
E
D000014:Abnormalities, Drug-Induced / Q000209:etiology; D000284:Administration, Oral; D000925:Anticoagulants / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001728:Dicumarol / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D004334:Drug Administration Schedule; D005260:Female; D006470:Hemorrhage / Q000139:chemically induced; D006493:Heparin / Q000008:administration & dosage; D006801:Humans; D007262:Infusions, Intravenous; D007275:Injections, Intravenous; D008297:Male; D011183:Postoperative Complications / Q000517:prevention & control; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000188:drug therapy; D011517:Prothrombin Time; D013923:Thromboembolism / Q000517:prevention & control*; D014859:Warfarin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use
D000925:Anticoagulants; D014859:Warfarin; D001728:Dicumarol; D006493:Heparin